Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8a80b9bef8381cbd855114f4801ba7df http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_98c7ad6a13a5ddd5fd189113c3d4b76f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a299386b7db5a705230298194d36aef |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-009 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2030-062 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-203332 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-25375 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10T436-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N1-405 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-7233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-82 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N30-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N1-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N30-72 |
filingDate |
2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_97c240cc18c00e0147cde3ef8f3282d6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_215555bb756459d76a40eebe1a38ed98 |
publicationDate |
2013-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8409865-B2 |
titleOfInvention |
Methods and kits for the determination of the presence and quantity of vitamin D analogs in samples |
abstract |
Embodiments of the present invention are directed to methods and kits for determining the presence or absence, and the amount if present, of vitamin D analogs in samples. One embodiment of the present method for detecting the presence or absence of vitamin D analogs in a sample comprises the steps of adding an effective amount of a multiple charge cationic agent to the sample to form a cationic treated sample. The effective amount of a multiple charge cationic agent enhances the signal from vitamin D analogs upon analysis by mass spectroscopy. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11161057-B2 |
priorityDate |
2008-02-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |